For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The Riboflavin, also known as vitamin B2, is a vitamin found in food and used as a dietary supplement. As a supplement it is used to prevent and treat riboflavin deficiency and prevent migraines. It can be used as a therapeutic mouth, eyes and genital inflammation APIs. Riboflavin application is very extensive in the clinical treatment, food industry, feed industry and has important value in cosmetic industry and so on.
LPI (LP Information)' newest research report, the "Vitamin B2 (Riboflavin) Industry Forecast" looks at past sales and reviews total world Vitamin B2 (Riboflavin) sales in 2022, providing a comprehensive analysis by region and market sector of projected Vitamin B2 (Riboflavin) sales for 2023 through 2029. With Vitamin B2 (Riboflavin) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vitamin B2 (Riboflavin) industry.
This Insight Report provides a comprehensive analysis of the global Vitamin B2 (Riboflavin) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vitamin B2 (Riboflavin) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vitamin B2 (Riboflavin) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vitamin B2 (Riboflavin) and breaks down the forecast by content, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vitamin B2 (Riboflavin).
The global Vitamin B2 (Riboflavin) market size is projected to grow from US$ 9237 million in 2022 to US$ 12890 million in 2029; it is expected to grow at a CAGR of 12890 from 2023 to 2029.
Global Vitamin B2 (Riboflavin) main players are Guangji Pharmaceutical, DSM, BASF, Shanghai Acebright Pharmaceuticals, etc. Global top four manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share nearly 40%.
This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin B2 (Riboflavin) market by product content, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by content
- 80% Vitamin B2
- 80%~96% Vitamin B2
- 98%~102% Vitamin B2
Segmentation by application
- Feed Additives
- Food Additives
- Pharmaceutical and Cosmetic
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Guangji Pharmaceutical
- DSM
- BASF
- Shanghai Acebright Pharmaceuticals
- NB GROUP
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vitamin B2 (Riboflavin) market?
What factors are driving Vitamin B2 (Riboflavin) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vitamin B2 (Riboflavin) market opportunities vary by end market size?
How does Vitamin B2 (Riboflavin) break out content, application?
What are the influences of COVID-19 and Russia-Ukraine war?